成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Shanghai Aladdin Biochemical Technology Co.,Ltd.

Firmenname:Shanghai Aladdin Biochemical Technology Co.,Ltd.
Telefon:400-6206333
E-Mail:market@aladdin-e.com
Nationalit?t:China
URL: www.aladdin-e.com/
Produkte insgesamt:48461
460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485

Produktkatalog

Brentuximab (anti-TNFRSF8)2088770-90-3
Motavizumab (anti-RSV-F)677010-34-3
Zanamivir139110-80-8C12H20N4O7
Zandelisib1401436-95-0C31H38F2N8O
Farletuzumab (anti-FOLR1)896723-44-7
Blosozumab (anti-SOST)1132758-87-2
Aprutumab (anti-FGFR2)1634620-63-5
Etokimab (anti-IL-33)2022981-44-6
Zileuton (A-64077)111406-87-2C11H12N2O2S
Omalizumab (anti-IgE)242138-07-4
Tregalizumab (anti-CD4)1207446-68-1
Fletikumab (anti-IL-20)1357158-22-5
Abituzumab (anti-ITGAV)1105038-73-0
Tiragolumab (anti-TIGIT)1918185-84-8
Belantamab (anti-TNFRSF17)2061894-48-0
Mupadolimab (anti-CD73)2451856-97-4
Mepolizumab (anti-IL-5)196078-29-2
Lorvotuzumab (anti-CD56)339306-30-8
Zoledronic Acid Disodium Salt Tetrahydrate165800-07-7C5H13N2NaO8P2
Zinc acetylacetonate hydrate108503-47-5C10H14O4Zn
Zalcitabine7481-89-2C9H13N3O3
Canakinumab (Anti-IL-1b)914613-48-2
Sifalimumab (anti-IFNa1)1006877-41-3
Onartuzumab (anti-MET)1133766-06-9
Anifrolumab (anti-IFNAR1)1326232-46-5
Rovalpituzumab (anti-DLL3)1613313-01-1
Omburtamab (anti-CD276)1895083-75-6
Nadunolimab (anti-IL-1 RAcP)2171061-85-9
Zolantidine dimaleate104076-39-3C22H27N3OS2C4H4O4
Zibotentan (ZD4054)186497-07-4C19H16N6O4S
Necitumumab (anti-EGFR)906805-06-9
Zolmitriptan139264-17-8C16H21N3O2
Zirconium acetateZirconiumacetat7585-20-8C2H4O2Zr
Zirconium hydroxideZirconiumtetrahydroxid14475-63-9H4O4Zr
Recombinant Human VEGF Protein127464-60-2NULL
Z-LEHD-FMK TFA524746-03-0C34H44F4N6O12
Figitumumab (anti-IGF1R)943453-46-1
Naxitamab (anti-GD2)1879925-92-4
ZM 306416690206-97-4C16H13ClFN3O2
Zilovertamab (anti-ROR1)2485779-13-1
Zearalenone from Giberella zeae3,4,5,6,9,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacy-clotetradecin-1,7(8H)-dion,(S-(E))-17924-92-4C18H22O5
Tremelimumab (anti-CTLA-4)745013-59-6
Zaltoprofen10,11-Dihydro-α-methyl-10-oxodibenzo[b,f]thiepin-2-essigsure74711-43-6C17H14O3S
Zoledronic Acid118072-93-8C5H10N2O7P2
Zebularine (NSC 309132)3690-10-6C9H12N2O5
Amatuximab (anti-MSLN)931402-35-6
Mavrilimumab (anti-CD116)1085337-57-0
Olokizumab (anti-IL-6)1007223-17-7
Pamrevlumab (anti-CTGF)946415-13-0
Selicrelumab (anti-CD40)1622140-49-1
Spartalizumab (anti-PD-1)1935694-88-4
Envafolimab (anti-PD-L1)2102192-68-5
Vibostolimab (anti-TIGIT)2231305-30-7
Teplizumab (anti-CD3e)876387-05-2
Sotigalimab (anti-CD40)2305607-45-6
Cusatuzumab (anti-CD70)1864871-20-4
Vedolizumab (anti-α4β7-integrin)943609-66-3
Fezakinumab (anti-IL-22)1007106-86-6
Etrolizumab (anti-α4β7)1044758-60-2
Simtuzumab (anti-LOXL2)1318075-13-6
Emapalumab (anti-IFNγ)1709815-23-5
Relatlimab (anti-LAG-3/CD223)1673516-98-7
Onvatilimab (anti-VISTA)1969313-51-6
Penpulimab (anti-PDCD1)2350298-92-7
ZM 39923 HCl1021868-92-7C23H26ClNO
Aducanumab (anti-APP)1384260-65-4
Zinc PyrithioneBis(1-hydroxy-2(1H)-pyridinthiona-to-O,S)zink13463-41-7C10H8N2O2S2Zn
Ibalizumab (anti-CD4)680188-33-4
Bemarituzumab (anti-FGFR2)1952272-74-0
Sabatolimab (anti-TIM-3)2252262-24-9
Zinc iron oxideDieisenzinktetraoxid12063-19-3Fe2O4Zn
Evolocumab(anti-PCSK9)1256937-27-5
Patritumab (anti-ERBB3)1262787-83-6
Otelixizumab (anti-CD3)881191-44-2
Teprotumumab (anti-IGF1R)1036734-93-6
Evinacumab (anti-ANGPTL3)1446419-85-7
Oleclumab (anti-CD73)1803176-05-7
Magrolimab (anti-CD47)2169232-81-7
Panitumumab (anti-EGFR)339177-26-3
Muromonab (anti-CD3)140608-64-6
Denosumab (anti-TNFSF11)615258-40-7C6404H9912N1724O2004S50
Eptinezumab (anti-CGRP)1644539-04-7
Varlilumab (anti-TNFRSF7)1393344-72-3
Zinc fluoborate hydrate27860-83-9BF4H2OZn+
Zafirlukast (ICI-204219)107753-78-6C31H33N3O6S
Mirvetuximab (anti-FOLR1)1453084-36-0
Sacituzumab (anti-TROP2)1796566-95-4
Zinc selenideZinkselenid1315-09-9SeZn
Sofituzumab (anti-MUC16)1615692-28-8
Ofatumumab (anti-CD20)679818-59-8
Emicizumab (anti-Factor IX)1610943-06-0
Brodalumab (anti-IL17RA)1174395-19-7
Risankizumab (anti-IL-23)1612838-76-2
Z-FA-FMK197855-65-5C21H23FN2O4
Siltuximab (anti-IL-6)541502-14-1
Margetuximab (anti-HER2)1350624-75-7
Isatuximab (anti-CD38)1461640-62-9
Erenumab (anti-CALCRL)1582205-90-0
Sintilimab (anti-PD-1)2072873-06-2
Talquetamab (anti-GPRC5D)2226212-40-2
460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485
Copyright 2019 ? ChemicalBook. All rights reserved